Results 161 to 170 of about 15,954 (238)

Sonographic Signatures of Immune Checkpoint Inhibitor-Associated Musculoskeletal Adverse Events. [PDF]

Cancers (Basel)
von Eckstaedt HV, Weng K, Sacksen I, Stovall R, Grivas P, Bhatia S, Hall E, Pollock S, Singh N.   +8 more
europepmc   +1 more source

To Screen or Not to Screen: "False Positive" Cases-Can They Be Treated as Definitely False? Properly Selecting the Screening Age-Range Groups in Scoliosis Screening Programs. [PDF]

Healthcare (Basel)
Grivas TB, Vasiliadis E, Mazioti C, Mamzeri A, Papagianni D, Katzouraki G, Sekouris N.   +6 more
europepmc   +1 more source

Single-Hit and Multi-hit PIK3CA Short Variant Genomic Alterations in Clinically Advanced Prostate Cancer: A Genomic Landscape Study. [PDF]

Target Oncol
Basin MF, Miguel CM, Jacob JM, Goldberg H, Grivas P, Spiess PE, Necchi A, Kamat AM, Pavlick DC, Huang RSP, Lin DI, Danziger N, Sokol ES, Sivakumar S, Graf R, Cheng L, Vasan N, Ross J, Basnet A, Bratslavsky G.   +19 more
europepmc   +1 more source

Successful treatment of immune checkpoint inhibitor-associated fulminant myocarditis with abatacept and ruxolitinib: a case report. [PDF]

Eur Heart J Case Rep
Wadden E, Lai C, Grivas P, Bhatia S, Portuguese AJ, Salem JE, Moslehi JJ, Cheng RK.   +7 more
europepmc   +1 more source

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer. [PDF]

J Clin Oncol
Necchi A, Galsky MD, Dizman N, Aggen DH, Agarwal N, Al-Ahmadie H, Apolo AB, Ballas L, Bangs R, Black PC, Brausi M, Brembilla G, Cheng L, Chiti A, Cimadamore A, Colecchia M, Daneshmand S, Di Stasi S, Efstathiou JA, Filicevas A, Geynisman DM, Grivas P, Gupta S, Iasonos A, James ND, Lerner SP, Loriot Y, Makaroff LE, Maluf F, Moschini M, Ostrovnaya I, Pal SK, Plimack ER, Prakash G, Psutka SP, Rosenberg JE, Sadeghi S, Schmidt B, Schwartz LH, Sonpavde GP, St Laurent MP, Ye D, Spiess PE, Kamat AM.   +43 more
europepmc   +1 more source

Avelumab maintenance treatment for advanced urothelial cancer: plain language summary of long-term results from the JAVELIN Bladder 100 study. [PDF]

Future Oncol
Powles T, Park SH, Gurney H, Loriot Y, Sridhar SS, Bellmunt J, di Pietro A, Grivas P.   +7 more
europepmc   +1 more source

A new specimen of the ornithischian dinosaur Haya griva, cross-Gobi geologic correlation, and the age of the Zos Canyon beds

, 2016
Mark. Norell, Daniel E. Barta
openaire   +1 more source

Computational models for predicting bone fracture healing: a review of modeling approaches, predictions, and emerging strategies. [PDF]

Biomech Model Mechanobiol
Pires DG, Completo A, Santos MPSD.
europepmc   +1 more source

Blood-Epigenetic Biomarker Associations with Tumor Immunophenotype in Patients with Urothelial Carcinoma from JAVELIN Bladder 100. [PDF]

Cancers (Basel)
Powles T, Sridhar SS, Bellmunt J, Sternberg CN, Grivas P, Hunter E, Salter M, Powell R, Dring A, Green J, Akoulitchev A, Ronen R, Dutkowski J, Amezquita R, Huang CH, Fernandez D, Nameki R, Ching KA, Pu J, Saul M, Deng S, di Pietro A, Davis CB.   +22 more
europepmc   +1 more source

On the Horizon: A Global Multidisciplinary Perspective on Delivering Emerging Therapies for Patients with BCG-Naïve High-Risk NMIBC. [PDF]

Oncol Ther
Szabados BE, Guerrero-Ramos F, Grande E, Grivas P, Grünwald V, Miguel MC, Hussain SA, Kulkarni GS, Wilson AL, Shore ND, Sridhar SS, Hoyt M, Strumeier S, Sutton J, Brinkmann J, Teresi RE, Todenhöfer T.   +16 more
europepmc   +1 more source